Handbook of Cancer Chemotherapy for PDA

SECTION 1 HISTORICAL ASPECTS 1. Early Description and Key Contributions to Understanding Non-Hodgkin's Lymphomas 2. Development of the Histopathologic Classifications of Lymphomas 3. The History of Chemotherapy of Lymphomas and Description of Early Trials 4. The History of Radiation Therapy of Lymphomas and Description of Early Trials SECTION 2 ETIOLOGY AND EPIDEMIOLOGY 5. Overview of the Etiology and Epidemiology of Lymphoma 6. Lymphoma and Abnormalities of the Immune System 7. Lymphoma as an Infectious Disease SECTION 3 BIOLOGY AND PATHOLOGY 8. Development and Functional Biology of B Lymphocytes 9. Developmental and Functional Biology of T Lymphocytes 10. The REAL and WHO Classifications of Lymphoid Neoplasms 11. Immunophenotyping in Lymphoma Diagnosis and Classification 12. Lymphokines and Cytokines in Lymphoma 13. Cytogenetics of Lymphoma 14. Molecular Genetics of Lymphoma 15. The Relationship Between Non-Hodgkin's Lymphomas and Hodgkin's Disease SECTION IV. STAGING AND INITIAL EVALUATION 16. Diagnostic Procedures 17. Initial Evaluation: Staging and Prognostic Factors 18. Diagnostic Radiology 19. Nuclear Medicine SECTION V. TREATMENT PRINICPLES AND TECHNIQUES 20. Principles of Radiation Therapy 21. Principles of Chemotherapy and Combined Modality Therapy 22. Biologic Therapy 23. Principles of High Dose Therapy SECTION VI. PATHOLOGY, BIOLOGY, CLINICAL EVALUATION AND SELECTION OF TREATMENT 24. Small B-Lymphocytic Lymphomas/Chronic Lymphocytic Leukemia, B-cell Prolymphocytic Leukemia 25. Lymphoplasmacytoid Lymphoma/Waldenstrom's Macroglobulinemia 26. Splenic Marginal Zone Lymphoma 27. T-cell Large Granular Lymphoproliferative Disease 28. HTLV 1-Associated Adult T-cell Lymphoma/Leukemia 29. Mycosis Fungoides 30. Cutaneous B-cell Lymphomas 31. CD30+ Cutaneous Lymphoproliferative Disease (ALCL and Lymphomatoid Papulosis 32. Extranodal Marginal Zone/MALT Lymphoma 33. Nodal Marginal Zone/MALT Lymphoma 34. Follicular Lymphoma 35. Mantle Cell Lymphoma 36. Diffuse Large B-cell Lymphoma 37. Primary Mediastinal Large B-cell Lymphoma 38. T-cell Anaplastic Large Cell Lymphoma 39. Mature Nodal and Extra-nodal T-cell and NK-cell Lymphomas 40. Burkitt's Lymphoma 41. Precursor B and T-cell Lymphoblastic Lymphoma 42. Plasma Cell Neoplasms: Multiple Myeloma and Plasmacytoma SECTION VII. LATE EFFECTS 43. Second Tumors 44. Late Effects of Treatment After Lymphoma 45. Assessing the Quality of Life in Patients with Lymphoma: Instruments and Clinical Trials SECTION VIII. SPECIAL TOPICS 46. Management of Lymphoma in Children 47. Management of Lymphoma in the Elderly 48. Management of Lymphoma During Pregnancy 49. Management of HIV Related Lymphoma 50. Diagnosis and Management of Post-Transplant and Other Iatrogenic Immune Deficiency Lymphoproliferative Disorders 51. Management of CSN Lymphoma 52. Metabolic Disorders Associated with Lymphoma 53. Diagnosis and Management of Lymphoproliferative Disorders that can Mimic Lymphoma 54. Unique Aspects of Extranodal Lymphoma